Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-93.70	-40.83	647.99
Graham Fair Price	1324.24	3.98	0.28
PEG	-99.91	0.01	-15.35
Price/Book	10.20	0.68	0.62
Price/Cash Flow	173.60	39.08	-14.29
Prices/Earnings	-99.48	-8.11	1546.42
Price/Sales	3.68	0.88	0.85
Price/FCF	173.60	39.08	-14.29
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-14.97	< 0.005	< 0.005
Operating Margin	-1390.13	-0.03	< 0.005
ROA	20309.57	-0.01	< 0.005
ROE	< 0.005	-0.02	20926.40
ROIC	< 0.005	-0.01	-973.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.32	0.04	624.95
Dividends QOQ	0.06	-1.00	1601.55
EBIT QOQ	0.97	-12.08	1150.42
EPS QOQ	1.01	-6.04	499.92
FCF QOQ	-3.57	-0.65	81.83
Revenue QOQ	-0.03	0.01	-57.72
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	37.19	33.61	-9.63
Days Sales Outstanding (DSO)	8.69	9.53	9.59
Inventory Turnover	2.42	2.68	10.66
Debt/Capitalization	0.36	0.39	6.59
Quick Ratio	0.42	0.45	8.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	5.90	12.16	106.20
Cash	1.23	1.54	24.93
Capex	-0.10	0.11	9.95
Free Cash Flow	-0.25	0.10	-60.44
Revenue	4.28	4.47	4.40
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	0.89	0.82	-8.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	245.24	-7.89	-96.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating